Business Description
Hemogenyx Pharmaceuticals is a London-based company working to develop new medicines for blood cancers and related diseases. Its main focus is a treatment called HG-CT-1, aimed at patients with a hard-to-treat form of leukemia that has not responded to existing therapies. The company is also working on several other approaches, including antibody-based treatments designed to improve the safety and success of bone marrow transplants, as well as therapies targeting viral infections and certain neurological conditions.
